Pharmacist who exposed himself leaves NPA

The National Pharmacy Association (NPA) has said its education and training pharmacist who was suspended last year by the General Pharmaceutical Council (GPhC) for exposing himself in public is to leave the organisation.

After holding an internal disciplinary procedure, the NPA today said Alan Zangana was to depart having been handed a minimum six-month suspension by the regulator’s fitness to practise committee last November after an incident in February 2017 in which he was seen by a woman exposing his penis in the car park of a petrol station in Hemel Hempstead.

The NPA refused to say if it sacked him or if he resigned. An NPA spokesperson told ICP: “Alan Zangana is leaving our organisation. However, we wish to make clear that the incident investigated by the GPhC was unrelated to his work at the NPA.”

Zangana, whose employment at the NPA started in January 2015, was its education and training manager from April 2017, a role that saw him write and deliver training content and courses. The GPhC noted he was “not actually involved in dispensing drugs in this employment.”

He was handed a police caution in March 2017 but failed to report the caution to the GPhC within seven days as required by its rules.

He again failed to declare the caution during the re-registration process in October 2017 and was even found to have inaccurately declared he had not received a caution.

As part of the caution, Zangana was required to write letters of apology to two women who had seen him expose himself, although he told the fitness to practise committee that the incident was a misunderstanding.

According to the committee’s determination, Zangana insisted he had been “putting ointment on his penis” and “had never intended anyone to see what he was doing.” That was rejected by the committee.

The GPhC said it did not consider that Zangana presented a risk to patients but ruled he had “failed to meet accepted standards of personal conduct.”

The regulator said there would be a review before the six-month suspension is up to determine if he should be allowed to return to practise.

 

Recommended

RPS calls for integral care home role for pharmacists

BMA: Measles vaccine rates ‘incredibly concerning’




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Independent Pharmacist's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.